Skip to main content

Perrigo Company Value Stock - Dividend - Research Selection

Perrigo

ISIN: IE00BGH1M568 , WKN: A1XAEY

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, and anti-parasite categories. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force in North America, Europe, Australia, Israel, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Dividend Champion, Contender, And Challenger Highlights: Week Of December 14

2025-12-12
Read the latest list of Dividend Champions, Contenders, and Challengers. Track changes, upcoming ex-dividend and pay dates here.

Perrigo (PRGO): Reassessing Valuation After Class Action Lawsuits and Cut Guidance on Infant Formula Business

2025-12-07
Perrigo (PRGO) is back in the spotlight after a wave of class action lawsuits hit the company, following weak quarterly results, a lowered 2025 outlook, and a strategic review of its infant formula business. See our latest analysis for Perrigo. The wave of lawsuits and the downgraded outlook have clearly rattled confidence, with a roughly 40% 3 month share price return and about a 50% 1 year total shareholder return both sharply negative. This signals fading momentum as investors reassess...

Is Perrigo A Bargain After A 48% Share Price Slide In 2025?

2025-12-07
If you are wondering whether Perrigo is a beaten down value play or a value trap at today’s price, you are not alone. This article will unpack exactly what the market might be missing. The stock has slid heavily over the longer term. It is down 48.3% year to date and 49.4% over the last year, even though it has been relatively stable in the last week with a 0.7% move and is down 6.9% over the last 30 days. Recent headlines have focused on Perrigo sharpening its portfolio around consumer self...

CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

2025-12-05
S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.

Perrigo (PRGO) Down 9.7% Since Last Earnings Report: Can It Rebound?

2025-12-05
Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Should You Hold Your Stake in Perrigo Company, plc (PRGO)?

2025-12-01
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities hit a record high in the third quarter, fueled by continued gains in technology and falling bond yields. Easing tariff rhetoric and renewed AI infrastructure investments boosted large tech stocks. […]

Dividend Champion, Contender, And Challenger Highlights: Week Of November 30

2025-11-21
See here for latest weekly updates on dividend changes, ex-dividend dates, and pay dates for Dividend Champions, Contenders, and Challengers.

Perrigo to Attend Morgan Stanley Global Consumer & Retail Conference

2025-11-18
Perrigo Company plc (NYSE: PRGO), a leading provider of consumer health products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to participate in one-on-one investor meetings at the Morgan Stanley Global Consumer & Retail Conference on Tuesday, December 2nd, 2025.

Canaccord Maintains Buy on Perrigo (PRGO) While Cutting Price Target to $20

2025-11-17
Perrigo Company plc (NYSE:PRGO) is included among the 15 Best 52-Week Low Dividend Stocks to Invest in. On November 6, C‍anaccord lowered its price ta⁠rge​t⁠ on Perrigo Company plc (NYSE:PRGO) to $20 from $40, w‍hile maintaining a Buy rating on the stock, as reported by The Fly. The‌ firm not‍ed t​hat although Q3 re‌sults‌ bea⁠t […]

Perrigo (PRGO) Price Target Decreased by 38.95% to 19.72

2025-11-17